BRASILIA, Nov 10 — Pfizer Inc plans to seek Brazil’s authorisation to use its Covid-19 vaccine in children aged 5 to 11 years, the country’s health regulator Anvisa said yesterday after a meeting with the US company.
The dose for children aged 5 to 11 years will be lower than the dose for children over the age of 12 due to a new formula developed by the company, Anvisa said. Almost 610,000 Brazilians have died from Covid-19, according to health ministry data, in the world’s third worst outbreak outside the United States and India and its second-deadliest.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: